| 2026 | Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma
| JOURNAL OF EXTRACELLULAR VESICLES |
| 2026 | Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer
| GENOME BIOLOGY |
| 2026 | High-resolution functional mapping of androgen receptor variants | NATURE BIOMEDICAL ENGINEERING |
| 2026 | A regulatory axis for tonotopic MYO7A expression in cochlear hair cells | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
| 2026 | A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death
| FRONTIERS IN ONCOLOGY |
| 2026 | Rare missense variants in MYO7A and OTOP2 genes in a South Korean Meniere's disease cohort | JOURNAL OF MEDICAL GENETICS |
| 2026 | Development and Performance Validation of a Comprehensive Liquid Biopsy Genotyping Panel for Pan-cancer Analysis | ANNALS OF LABORATORY MEDICINE |
| 2026 | Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs
| CANCER RESEARCH |
| 2026 | A 62-aa core of the cochlin LCCL domain induces macrophage M1 polarization in vitro | INFLAMMATION RESEARCH |
| 2026 | HAP1 interaction with KCNQ4 attenuates channel surface expression and function | MOLECULES AND CELLS |
| 2026 | Integration of PNPLA3 and TM6SF2 genotypes provides incremental improvement in advanced fibrosis prediction among MASLD patients with type 2 diabetes mellitus
| JHEP REPORTS |
| 2026 | Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus
| NATURE COMMUNICATIONS |
| 2026 | Obinutuzumab induces lysosomal destabilization via sphingomyelin-dependent inhibition of TRPML2
| SCIENTIFIC REPORTS |
| 2026 | A comprehensive functional atlas of ALK kinase domain variants reveals resistance landscape to ALK inhibitors
| GENOME BIOLOGY |
| 2026 | Gene supplementation with precise transgene expression rescues hearing loss in a mouse model with an Mpzl2 East Asian founder variant | MOLECULAR THERAPY |
| 2026 | A predictive framework for stop-loss variants with C-terminal extensions | NUCLEIC ACIDS RESEARCH |
| 2026 | Evaluation and prediction of guide RNA activities in genome-editing tools | NATURE REVIEWS BIOENGINEERING |
| 2026 | Pharmacological chaperones mitigate noise- induced hearing loss by attenuating sustained PERK activation | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
| 2025 | Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa
| MSYSTEMS |
| 2025 | Recent preclinical and clinical advances in gene therapy for hereditary hearing loss
| MOLECULES AND CELLS |
